Discovery of SIRT7 Inhibitor as New Therapeutic Options Against Liver Cancer
Chen Zhang(Second Affiliated Hospital of Nanjing Medical University), Zhuan Li(Hunan Normal University)
Cited by 40
Related Papers
SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway
|Journal of Experimental & Clinical Cancer Research|2019|92
Serine 574 phosphorylation alters transcriptional programming of FOXO3 by selectively enhancing apoptotic gene expression
|Cell Death and Differentiation|2015|60
CD36 deficiency ameliorates drug-induced acute liver injury in mice
|Molecular Medicine|2021|23
Hepatic ROS Mediated Macrophage Activation Is Responsible for Irinotecan Induced Liver Injury
|Cells|2022|20
CYP2E1-dependent upregulation of SIRT7 is response to alcohol mediated metastasis in hepatocellular carcinoma
|Cancer Gene Therapy|2022|19